Could mass drug administration wipe out malaria in ghanaian communities?
NCT ID NCT07389057
First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 9 times
Summary
This study aims to see if giving a combination of malaria drugs (DHAP and primaquine) to everyone in high-risk communities can reduce malaria infections and stop the disease from spreading. About 9,000 people aged 3 months and older will receive the drugs every two months for a year. The goal is to find a practical way to lower malaria rates and inform national health policy.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALARIA,FALCIPARUM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Pokrom sub district
RECRUITINGAccra, Eastern Region, 233, Ghana
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.